Contemporary Evidence in Sinonasal Malignancy Treatment 2026
09-11, 11:15–12:45 (Europe/Istanbul), Rhinology 1 (ICC - B2 level BEYAZIT)

Contemporary Evidence in Sinonasal Malignancy Treatment 2026

Moderator Moderator

Edward Kuan, MD, MBA, FARS is Division Chief of Rhinology and Skull Base Surgery, co-director of the Comprehensive Skull Base Program, and Professor of Otolaryngology-Head and Neck Surgery and Neurological Surgery at the University of California, Irvine. He received his medical degree from UC Irvine. He then completed residency training in otolaryngology-head and neck surgery at UCLA, followed by fellowship training in rhinology and skull base surgery at the University of Pennsylvania.

His research interests include evidence-based skull base reconstruction and biological basis of and management principles for sinonasal tumors. He has published more than 350 peer-reviewed original articles, reviews, and book chapters in the highest-impact otolaryngology and neurosurgery journals and is a regular invited speaker for both clinical topics and his research nationally and internationally. He is actively involved in the American Rhinologic Society, serving on the Board of Directors as Education Coordinator; North American Skull Base Society; and Triological Society, where he is a fellow member.

He is the primary editor of a textbook on skull base reconstruction and is the primary editor of the International Consensus Statement on Allergy and Rhinology - Sinonasal Tumors document. He also serves as an associate editor of International Forum of Allergy & Rhinology and American Journal of Rhinology & Allergy, and also on the editorial board of Rhinology.

This speaker also appears in:

Ehab Hanna, M.D., FACS, is an internationally recognized head and neck surgeon and expert in the treatment of patients with skull base tumors and head and neck cancer. Dr. Hanna is currently a Professor and Vice Chair of the Department of Head and Neck Surgery with a joint appointment in the Department of Neurosurgery, MD Anderson Cancer Center. He also serves as an Adjunct Professor of Otolaryngology and Head and Neck Surgery at Baylor College of Medicine. He served as the medical director of the Multidisciplinary Head and Neck Center for 20 years (2004-2023) and is currently the director of the Skull Base Tumor program. For the last 15 years, Dr. Hanna has consistently been named one of America's Best Doctors and Top Doctors in Cancer. In addition to patient care, Dr. Hanna is actively engaged in clinical and translational research with emphasis on skull base tumors. He authored over 350 publications, invited articles, book chapters, and editorials. He co-edited several major textbooks on Cancer of the Head and Neck, Cancer of the Larynx, and Comprehensive Management of Skull Base Tumors. He served as the Editor-in-Chief of the journal of Head & Neck for 15 years from 2007 to 2022. Dr. Hanna served as the President of the North American Skull Base Society (2013-2014) and the President of the American Head and Neck Society (2018-2019). He is currently the Secretary General of the International Federation of Head & Neck Oncologic Societies, the largest organization in the world for Head and Neck Oncology.

This speaker also appears in: